BiomX Inc (PHGE) stock poised to deliver a potential return of 217.46%

At the time of writing, BiomX Inc [PHGE] stock is trading at $0.63, up 27.59%. An important factor to consider is whether the stock is rising or falling in short-term value. The PHGE shares have gain 20.91% over the last week, with a monthly amount drifted -2.48%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

BiomX Inc [AMEX: PHGE] stock has seen the most recent analyst activity on April 15, 2021, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $25.

For the past year, the stock price of BiomX Inc fluctuated between $0.48 and $4.99. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. BiomX Inc [AMEX: PHGE] shares were valued at $0.63 at the most recent close of the market. An investor can expect a potential return of 217.46% based on the average PHGE price forecast.

Analyzing the PHGE fundamentals

Gross Profit Margin for this corporation currently stands at 11.77% with Operating Profit Margin at 125.07%, Pretax Profit Margin comes in at 33.57%, and Net Profit Margin reading is 108.07%. To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -1.23 and Total Capital is -0.63. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.26.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.5527 points at the first support level, and at 0.4765 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7026, and for the 2nd resistance point, it is at 0.7763.

Ratios To Look Out For

It is important to note that BiomX Inc [AMEX:PHGE] has a current ratio of 2.48. On the other hand, the Quick Ratio is 2.48, and the Cash Ratio is 2.63.

Transactions by insiders

Recent insider trading involved OrbiMed Israel BioFund GP Limi, 10% Owner, that happened on May 15 ’24 when 24344.0 shares were sold.

Related Posts